2-HG is a competitive inhibitor of α-KG-dependent dioxygenases in gliomas and hematological malignancies that carry mutations of isocitrate dehydrogenase genes (IDH1 and IDH2)61,62. The gene discussed is IDH3A; the disease is central nervous system cancer.